Welcome to our dedicated page for Afya news (Ticker: AFYA), a resource for investors and traders seeking the latest updates and insights on Afya stock.
Afya Limited reports financial, regulatory and capital-allocation developments for a Brazil-based medical education group and medical practice solutions provider. The company serves medical students and physicians through an end-to-end ecosystem that includes undergraduate medical education, residency preparation, continuing medical education, graduate programs and practice-management solutions.
Recurring company developments include IFRS financial results in Brazilian reais, medical-seat authorizations from Brazil’s Ministry of Education, campus-level capacity changes, credit-rating actions, dividends, share repurchases and board changes. Afya also reports activity in continuing education, B2B revenue, clinical management tools and the broader physician base that uses its education and medical practice platforms.
Afya Limited (Nasdaq: AFYA) announced it will report its first quarter 2020 financial results on May 28, 2020, after market close. The corresponding conference call and webcast are scheduled for May 29 at 11:00 AM EDT. Investors can access the call via phone or through the company's Investor Relations website. Afya is a prominent medical education group in Brazil, focusing on delivering comprehensive educational services for medical students and professionals.
Afya Limited (Nasdaq: AFYA) announced the acquisition of Centro Universitário São Lucas (UniSL) for R$341.6 million, enhancing its medical education capacity. This acquisition provides Afya with 182 additional medical school seats, increasing its total to 1,866. In 2019, UniSL generated gross revenues of R$227.5 million, primarily from health-related programs. The payment structure includes 70% upon closing and the remaining 30% in three installments, potentially increasing by R$80 million if additional seats receive government approval.